R ecent prospective studies evaluating the prevalence of obstructive sleep apnea (OSA) in the general pediatric population using polysomnography (PSG) have estimated the prevalence to range from 1.2% to 5.8% (1) (2) (3) . Pediatric OSA is an important cause of morbidity and, if untreated, can lead to adverse effects on growth, behaviour, cognition and cardiopulmonary function (4) . Children with craniofacial deformities, including cleft lip and palate (CL/P), are at increased risk for OSA due to abnormalities in the naso-and oropharyngeal anatomy present from birth or acquired as a result of surgical intervention (5, 6) . Children with CL/P commonly exhibit midface hypoplasia and a retrognathic maxilla, which persist after surgical intervention (7, 8) . Moreover, surgical treatments for oral rehabilitation include palato-and pharyngoplasty, which have been shown to increase OSA risk (6) (7) (8) . However, despite its adverse effects, little is known about the incidence of OSA in this high-risk population.
Despite the paucity of literature, the American Academy of Pediatrics acknowledges an increased risk for OSA in children with CL/P (9) . Previous studies involving children with CL/P are limited by highly heterogeneous study populations, small patient cohorts and specific surgical interventions. From an epidemiological perspective, children with isolated, nonsyndromic CL/P constitute the majority of patients seen at most cleft clinics (10) . Thus, it makes empirical sense to characterize the risk for OSA in this specific population. Furthermore, although PSG remains the gold standard for OSA diagnosis, issues of cost and access to care commonly limit the clinical utility of this tool. Thus, it has been suggested that the majority of children in the United States are treated for OSA based purely on clinical assessment without a PSG diagnosis (11) .
In the present study, we used a validated screening tool to assess the incidence of OSA symptoms in children with isolated, nonsyndromic CL/P treated at a large urban cleft centre. We hypothesized that this patient population is at high risk for positive OSA screening. Secondary objectives aimed to characterize clinical and demographic variables that increase risk for positive OSA screening.
METHODS
An Institutional Review Board-approved retrospective chart review was performed on consecutive patients evaluated at the Cleft Clinic at the Children's Hospital of Philadelphia (Pennsylvania, USA) between January 2011 and August 2013. As part of standard clinical care, the Sleep-Related Breathing Disorder subscale of the Pediatric Sleep Questionnaire (PSQ) was prospectively administered to all patients cared for at the Cleft Clinic during the study period. This validated tool is a parent-completed survey that predicts moderate to severe OSA with a sensitivity of 83% and a specificity of 87% in otherwise healthy children (12) . The PSQ consists of 22 'yes/no' questions regarding symptoms of sleep-disordered breathing, daytime sleepiness and behavioural issues. Questionnaires were scored by the number of positive responses; a ratio of positive to total responses >0.33 was considered to be a positive OSA screen. Unanswered questions were L'incidence du dépistage positif de l'apnée obstructive du sommeil chez les patients ayant une fente labiale ou palatine isolée OBJECTIF : Déterminer l'incidence d'apnée obstructive du sommeil (AOS) chez les enfants ayant une fente labiale ou palatine isolée (F/LP). MÉTHODOLOgIE : La présente étude prospective a été effectuée dans un centre de soins tertiaires. Des patients consécutifs évalués à la clinique de fente labiale ou palatine entre janvier 2011 et août 2013 ont été repérés. Les familles des patients ont rempli prospectivement un questionnaire sur le sommeil pédiatrique (PSQ), un outil validé utilisé pour prédire l'AOS modérée à grave. Les patients ayant une F/LP et un syndrome sous-jacent ou un autre diagnostic crâniofacial étaient exclus. eliminated from the survey so that ratios were generated only from the number of answered questions. In the event that an answer other than 'yes' or 'no' was recorded, the answer was considered to be a positive response unless clear evidence argued to the contrary. For example, a written answer response of 'sometimes' was considered a positive response equivalent to 'yes'.
A chart review was performed on all patients who completed the PSQ to obtain demographic information, clinical diagnoses and surgical history. Demographic variables included age at time of survey, sex, body mass index (BMI) and ancestry. For purposes of comparison, BMI was normalized to age-matched control data from the Centers for Disease Control & Prevention (Georgia, USA) and reported as a percentile. Measured weight was used if it was collected within six months of PSQ administration. Race was reported as Caucasian, African American, Hispanic or Asian. Only nonsyndromic children with isolated CL/P who were otherwise healthy were included in the present study. Patients with underlying chromosomal abnormalities or other craniofacial disorders were excluded. The diagnosis of CL/P was classified as isolated cleft lip (CL), submucosal cleft palate, and CL/P according to the Veau classification: cleft of the soft palate only (Veau I), cleft of the soft and hard palate (Veau II), unilateral complete CL/P (Veau III), and bilateral complete CL/P (Veau IV). Surgical status was documented based on the timing of surgical procedure relative to administration of the PSQ. Surgical procedures for primary cleft closure included Furlow double-reversing Z-palatoplasty and VeauWardill-Kilner V-Y pushback. Revision procedures included posterior pharyngeal flap (PPF) and sphincter pharyngoplasty (SPP). For purposes of comparison according to surgical status or clinical diagnosis, the Student's t test or ANOVA test with Tukey's method was used where appropriate. All statistical calculation was performed using STATA version 13 (StataCorp, USA); P<0.05 was considered to be statistically significant.
RESULTS
A total of 867 patients seen in the clinic were administered the PSQ during the study period and 489 with isolated CL/P met inclusion criteria. The mean (± SD) age at time of PSQ administration was 8.4±4.3 years (range two to 18 years). The cohort descriptors are shown in Table 1 . The study population was predominately male (59.5%) and Caucasian (60.7%). One-quarter of the cohort was Asian (25.9%). Nearly one-half of the subjects had a Veau class III cleft (49.7%) and nearly one-quarter had a Veau class IV cleft (23.2%).
Of children with nonsyndromic CL/P, 14.7% had a positive screen for OSA. Table 2 summarizes the prevalence of positive OSA screening according to age and sex. There was no conferred risk for positive screening according to either sex or age group in the cohort ( Figure 1 and Table 2 ). Table 3 summarizes the prevalence of positive OSA screening according to BMI percentile while Table 4 summarizes according to ancestry. Neither higher BMI percentile nor ancestry were associated with increased positive OSA screening. Moreover, there were no significant differences between cleft type and positive OSA screening (Table 5) .
The frequency of individual OSA symptoms was evaluated ( Table 6 ). The most commonly reported symptoms in the general population were 'mouth breather during the day' (29.5%), 'interrupts others' (27.2%) and 'fidgets with hands or feet' (25.6%). In children In contrast, children with a negative OSA screen most commonly reported 'mouth breather during the day' (21.3%), 'interrupts others' (19.4%), 'fidgets with hands or feet' (17.3%), 'on the go or driven by a motor' (17.3%) and 'occasionally wets the bed' (17.0%). Questions least predictive of a positive PSQ screen were 'fidgets with hands and feet' and 'easily distracted', with negative predictive values of 0.95. Additionally, questions most commonly blank were 'mouth breather during the day' (3.5%), 'wakes in the morning with a dry mouth' (3.7%) and 'occasionally wets the bed' (3.3%).
Thirty-two patients underwent PPF surgery before taking the PSQ (6.5%), and 12 underwent dynamic SPP. The mean time from surgery to completion of the PSQ was 5.83 and 5.56 years, respectively; 1.8% of patients underwent tonsillectomy before OSA screening and 2.0% underwent adenoidectomy. The mean time from surgery to completion of the PSQ was 4.82 and 4.61 years, respectively; 2.9% of patients underwent combined adenotonsillectomy. None of the interventions were associated with increased risk for positive OSA screening (P>0.05) ( Table 7) .
DISCUSSION
The present study used prospective administration of an OSA screening tool with retrospective chart review to report the prevalence of positive OSA screening in a large cohort of children with nonsyndromic CL/P. The prevalence of children with a positive screen was 14.7%. Thus, relative to their unaffected peers, children with CL/P may be seven times more likely to develop OSA symptoms (1-3). Our findings are consistent with the well-documented under-recognition of OSA in children with clefts (13, 14) . Because pediatric OSA is linked to delays in growth (4), neurodevelopment (15) and adverse metabolic effects (16) , it is plausible that delayed recognition of OSA is responsible for increased morbidity in children with CL/P. The majority of studies investigating OSA in children with cleft are limited through the use of heterogeneous cohorts of craniofacial patients and patients undergoing specific surgical interventions (17) (18) (19) . The present study is the first to report the prevalence of positive OSA screening in a large cohort of children with isolated, nonsyndromic CL/P.
A PSG can distinguish between OSAs and central sleep apneas, and recognize periodic limb movements and other sleep abnormalities that may mimic OSA symptoms. As such, it remains the gold standard in the diagnosis of OSA; however, in cases in which OSA is well documented clinically, PSG may not always be absolutely indicated (4) . In addition to its cost, inconvenience and lack of availability, PSG has numerous limitations that undermine its utility. Although PSG can be used to detect sleep abnormalities related to airway obstruction, gas exchange and disturbances in sleep architecture, it has never been validated to predict adverse clinical sequelae or response to medical treatment (20) . Thus, even in the absence of PSG confirmation, symptoms of sleep-disordered breathing commonly result in adverse neurocognitive and behavioural consequences. Furthermore, the lack of consistent acquisition between sleep laboratories and standard criteria for abnormal sleep studies further limits the utility of PSG as a diagnostic tool (21) . Thus, an important area of research is the development of effective OSA screening tools, thereby obviating the need for PSG clinically. While initially developed for research, the Chervin Pediatric Sleep Questionnaire (PSQ) is among the best screening tools for pediatric OSA (22) and, as such, is often used in the clinic (23) . The PSQ is a 22-question survey that asks questions related to snoring and troubled breathing, daytime sleepiness, inattentiveness and other common symptoms of pediatric OSA. This instrument has not been adequately studied in children with orofacial clefts and our study is the first to report PSQ findings in a large cohort of children with nonsyndromic CL/P. While unique in this homogenous population, several studies have reported PSQ findings from other craniofacial settings. MacLean et al (19) reported an incidence of positive OSA screening in 31.4% in a cohort of children with Pierre Robin sequence and underlying chromosomal abnormalities.
There were many items on the PSQ that were frequently underreported in the study cohort despite the high prevalence of positive OSA screening. There are several reasons to explain these differences and it must be emphasized that the PSQ was designed and validated for healthy children without CL/P. Children with these disorders have different etiologies for upper airway obstruction that may manifest as differences in 'normal' breathing. These differences can significantly alter the PSQ because symptoms of day-and night-time breathing account for approximately one-third of all questions. Additionally, families of children with CL/P may have an altered sensitivity to OSA symptoms as they are exposed to a lifetime of medical and surgical interventions that may alter their expectations. Furthermore, children with CL/P commonly demonstrate increased risk for impairments in neurocognitive function (24, 25) , which may be less likely related to OSA than in the general pediatric population. Similarly, factors in the general pediatric population commonly associated with increased risk for OSA failed to demonstrate a statistical correlation in our cohort, such as obesity, a well-established and increasingly common risk factor for OSA (26) . Additionally, some studies have shown increased prevalence and severity of OSA among African American children relative to their Caucasian peers (27, 28) . Finally, pediatric OSA has classically been described to exhibit male predominance (28); however, several large studies have found no significant difference in OSA prevalence according to sex (29, 30) . Again, differences in our results may be due to complex underlying medical conditions unique to this patient population.
OSA is a well-described complication of surgical interventions for the treatment of velopharyngeal insufficiency (17, 31, 32) . Despite possessing normal mandibular architecture, children with CL/P are at greater risk for upper airway obstruction. A deviated nasal septum is common in children with unilateral CL, and often results after surgical intervention (6) . Furlow palatoplasty can both lengthen and thicken the palate, and has a tendency to decrease airway space. Additionally, acute airway obstruction is well documented in patients undergoing PPF and SPP. This chronic obstruction can compromise the nasal airway and manifest as OSA. Interestingly, our study did not find an association between these interventions and increased risk for positive OSA screening. This could be secondary to the relatively small cohort of children with nonsyndromic cleft requiring these complex procedures or length of follow-up.
Combined adenotonsillectomy is the most common surgical procedure to address pediatric OSA (33) , with more than a half-million surgeries performed annually in the United States alone (34) . For children with CL/P, a partial instead of full adenoidectomy is frequently performed to prevent future velopharyngeal insufficiency. While common in the pediatric population, only 2.9% of children in our cohort underwent this procedure. Despite demonstrated benefits of a recent randomized control trial (35), we did not find a protective effect of adenotonsillectomy from positive OSA screening.
There were some limitations to the present study and, thus, future areas for investigation. The first is the nature of the screening tool we used to determine the prevalence of positive OSA screening. The PSQ validated by Chervin et al (12) had a reported sensitivity and specificity of 0.83 and 0.87, respectively, for the diagnosis of moderate to severe OSA in children two to 18 years of age. To validate the PSQ, overnight PSG was used. The American Academy of Pediatrics recognizes that, despite a lack of consensus, PSG is currently the best available tool for the diagnosis of OSA (9) . Until better tools are developed, PSG and screening questionnaires based on its reliability must be used in the diagnosis and treatment of OSA. Second, parents commonly omitted questions from the PSQ that did not pertain to their child. For example, the symptom of 'occasionally wets the bed' has limited applicability to a child still wearing diapers. This may compromise the utility of the PSQ and is a limitation of paper administration of the PSQ. Additionally, the present study was limited in the fact that a control group was not included for comparison and, as such, current published data were used. A control group would have increased the strength of our study by providing an objective benchmark for questionnaire results specific to our practice. With any retrospective study, our analysis was susceptible to inherent biases in patients presenting to clinic, transfer of care issues and different follow-up periods. Thus, we cannot draw strong conclusions regarding PSQ correlations with clinical variables.
CONCLUSIONS
One of seven children with isolated CL/P screened positively for OSA using PSQ. This is out of proportion to the general pediatric population, and highlights the potential importance of routine screening in this high-risk group. Future work will correlate these findings with diagnostic tests for OSA to determine true prevalence of the disease. 
